Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches-Reference-Cited by-同舟云学术

Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches

Published:2020-05-12 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Fisicaro Paola,Barili Valeria,Rossi Marzia,Montali Ilaria,Vecchi Andrea,Acerbi Greta,Laccabue Diletta,Zecca Alessandra,Penna Amalia,Missale Gabriele,Ferrari Carlo,Boni Carolina

Funder

Regione Emilia-Romagna

Ministero della Salute

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference192 articles.

1. What is needed to eliminate hepatitis B virus and hepatitis C virus as global health threats.;Ward;Gastroenterology.,2019

2. Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs).;Grossi;Liver Int.,2017

3. Perspectives and limitations for nucleo(t)side analogs in future HBV therapies.;Levrero;Curr Opin Virol.,2018

4. Current treatments for chronic hepatitis B virus infections.;Zoulim;Curr Opin Virol.,2016

5. Adaptive immunity in HBV infection.;Bertoletti;J Hepatol.,2016

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymph node-targeted STING agonist nanovaccine against chronic HBV infection;Cellular and Molecular Life Sciences;2024-08-28

2. Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu‐like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll‐like receptor 7 agonist ruzotolimod;Clinical and Translational Science;2024-08

3. HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B;Gut;2024-07-20

4. Rupestonic Acid Derivative YZH-106 Promotes Lysosomal Degradation of HBV L- and M-HBsAg via Direct Interaction with PreS2 Domain;Viruses;2024-07-17

5. Association of HLA-G 3′UTR polymorphisms with hepatitis B virus infection in Tunisian population;Immunologic Research;2024-07-06